A phase Ib/II study of the anti- CD47 antibody magrolimab with cetuximab in solid tumor and colorectal cancer patients

Authors
Category Primary study
JournalJournal of Clinical Oncology
Year 2020
This article has no abstract
Epistemonikos ID: ee34f8176ec837607c493550330ed8e21c67e034
First added on: Feb 11, 2025